Phase II study of bevacizumab in combination with S-1 plus cisplatin in patients with advanced nonsquamous non-small cell lung cancer.
Reiko Yoshino
No relevant relationships to disclose
Kyoichi Kaira
No relevant relationships to disclose
Yoshio Tomizawa
No relevant relationships to disclose
Toshifumi Kazama
No relevant relationships to disclose
Akihiro Yoshii
No relevant relationships to disclose
Yousuke Miura
No relevant relationships to disclose
Shinichi Ishihara
No relevant relationships to disclose
Naoto Fueki
No relevant relationships to disclose
Koichi Minato
No relevant relationships to disclose
Noriaki Sunaga
No relevant relationships to disclose